Erythromycin Suppositories 100mg | Macrolide Antibiotic for Bacterial Infections

Erythromycin Suppositories 100mg: What the Published Guidance Says

The obstetric emergency medicines and newborn-care antiseptics that sit on the WHO Model List — supplied with the labelling discipline these products demand.

This page collects the supply-relevant facts for Erythromycin Suppositories 100mg — specification, testing, packaging and the registration paperwork that travels with the batch.

• Chlorhexidine for umbilical cord care is an EMLca medicine Section 22.7 of the Model List carries chlorhexidine 7.1% digluconate solution or gel — delivering 4% chlorhexidine — for umbilical cord care, added in 2013. MSF specifies a 3 g gel applied once daily for seven days to the tip, stump and base of the cord. WHO eEML — Chlorhexidine (umbilical cord care)
• The protocol, and why presentation matters MSF describes two protocols: an intravenous/intramuscular schedule of 4 g by IV infusion over 15–20 minutes, then 10 g intramuscularly, then 5 g IM every four hours; and an IV-only schedule of 4 g over 15–20 minutes followed by 1 g per hour. Treatment continues for 24 hours after delivery or the last seizure. MSF Essential Drugs — Magnesium sulfate injectable
• Magnesium sulfate is the anticonvulsant for pre-eclampsia and eclampsia MSF lists magnesium sulfate injectable for severe pre-eclampsia (prevention of eclamptic seizures) and for eclampsia (treatment of seizures and prevention of recurrence), describing it as a calcium antagonist and anticonvulsant. The Model List also carries magnesium sulfate among antiseizure medicines. MSF Essential Drugs — Magnesium sulfate injectable

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Erythromycin Suppositories 100mg. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

How Erythromycin Suppositories 100mg Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Erythromycin Suppositories 100mg is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

• Testing for related substances and impurities
• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Erythromycin Suppositories 100mg Is Packed, Labelled and Shipped

• Pack size: Individually sealed suppositories (blister or foil pouch); typically 10 suppositories per box. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store in a cool place (below 25°C), protected from light. Keep away from heat. Keep suppositories in their sealed packaging until use..
• Shelf life: 36 months (unopened, when stored as directed). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Erythromycin Suppositories 100mg

Documents for Erythromycin Suppositories 100mg are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
• Batch manufacturing and packaging records released for inspection on request during supplier audits.

The context for Erythromycin Suppositories 100mg is its place among obstetric and newborn-care medicines named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.